CDKV Holdings’s Innospec IOSP Stock Holding History

CDKV Holdings’s Portfolio IOSP Stock Details IOSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.6K	Hold	400	–	–	0.03%	154
2026 Q1	$29.2K	Hold	400	–	–	0.03%	153
2025 Q4	$30.6K	Buy	+400	New	+$30.2K	0.03%	156

Other funds holding IOSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

CDKV Holdings's IOSP Position: Q2 2026 in Review

CDKV Holdings held its Innospec (IOSP) position steady in Q2 2026 at 400 shares worth $32.6K. The position accounts for 0.03% of the portfolio, ranked #154.

CDKV Holdings first reported a position in IOSP in Q4 2025 and has held it in 3 quarters since. 281 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.

CDKV Holdings held 400 shares of Innospec worth $32.6K as of Q2 2026.
CDKV Holdings left its Innospec share count unchanged in Q2 2026.
Innospec made up 0.03% of CDKV Holdings's portfolio in Q2 2026, its #154 holding.
CDKV Holdings first reported a position in Innospec in Q4 2025 and has held it in 3 quarters since.
281 funds tracked by Wall St. Rank held Innospec as of Q2 2026.

Based on CDKV Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.